Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q09470

Entry ID Method Resolution Chain Position Source
AF-Q09470-F1 Predicted AlphaFoldDB

369 variants for Q09470

Variant ID(s) Position Change Description Diseaes Association Provenance
rs776861490
RCV001217763
1 M>L Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs1947350138
RCV001241850
1 M>R Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs776861490
RCV001113418
1 M>V Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs529968149
RCV001113419
CA6399328
7 E>K Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1471834737
CA383453646
RCV000795415
10 D>E Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs777276806
RCV001235151
CA6399333
15 A>S Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
CA383453683
RCV001228030
rs1324506346
17 G>R Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV000560254
CA6399335
RCV003168608
rs367921276
RCV000415980
18 H>P Episodic ataxia type 1 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000517963
CA6399336
rs201504073
RCV000639376
20 Q>H Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000992234
CA6399337
rs747465523
RCV002550636
21 D>N Variant assessed as Somatic; 0.0 impact. Episodic ataxia type 1 [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA383453730
RCV001221665
rs1224258529
24 Y>H Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV002481619
RCV000504366
rs373645838
CA6399339
26 R>W Variant assessed as Somatic; 0.0 impact. Episodic ataxia type 1 [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
dbSNP
gnomAD
rs149959487
CA6399349
RCV000792773
RCV001289073
46 L>M Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
COSM1512344
RCV001299600
rs752067203
CA6399354
RCV002541895
60 N>S lung Episodic ataxia type 1 Inborn genetic diseases [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1947351910
RCV001114819
71 R>H Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs897263951
CA231855451
RCV001266289
RCV000560518
75 P>H Episodic ataxia type 1 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA231855475
RCV001114820
rs962399769
92 I>V Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1166033590
RCV001212684
CA383454225
97 Q>K Episodic ataxia type 1 Variant assessed as Somatic; impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
RCV001070533
rs1947352517
104 R>S Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
CA10642496
RCV000324825
rs886049510
RCV000379303
106 V>A Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs1591627522
CA383454338
RCV000819007
114 S>F Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA383454382
rs1463513823
RCV001313298
121 E>K Episodic ataxia type 1 Variant assessed as Somatic; impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA383454405
RCV000529699
rs1555085687
124 E>K Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA10632955
RCV000282894
RCV000347271
rs886049511
138 K>Q Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001220112
rs934102011
CA231855600
141 E>K Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs1947353699
RCV001109176
149 Y>C Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs1947353744
RCV001323018
151 R>C Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
CA6399392
rs764645312
RCV000712104
RCV001233194
159 Y>H Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000014426
rs104894349
CA256876
VAR_001508
RCV001265691
174 V>F Episodic ataxia type 1 Inborn genetic diseases EA1 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV001232347
rs104894349
174 V>I Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
CA256881
RCV000014432
rs267607195
177 I>N Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
VAR_001509 177 I>R EA1 [UniProt] Yes UniProt
CA256878
RCV000014428
rs104894357
VAR_020830
184 F>C Episodic ataxia type 1 EA1; alters voltage dependence and kinetics of activation though not of C-type inactivation [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000695125
CA383454826
rs1565433190
187 E>K Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1947354740
RCV001061166
195 D>E Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs1207573200
CA383454915
RCV001036830
199 T>M Variant assessed as Somatic; 0.0 impact. Episodic ataxia type 1 [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs1411072418
RCV000639377
CA383454920
200 G>A Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
VAR_020051
RCV000358778
RCV001088859
CA6399405
rs2229000
204 R>H Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1555085716
RCV000534163
209 T>missing Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
RCV001294866
rs764561596
CA6399409
214 S>F Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs762016621
RCV001316359
215 N>I Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
RCV001227873
CA383455038
rs1280516411
218 T>R Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
CA6399414
RCV001303541
rs146948558
223 I>V Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1947355480
RCV001347227
224 V>L Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
CA341287
VAR_001510
RCV003221784
RCV000014430
rs104894354
226 T>A Episodic ataxia type 1 EA1 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000014437
rs28933383
VAR_037100
CA123138
226 T>K Myokymia 1 MK1; induces a reduced efflux of potassium ions during depolarization which results in increased muscle cell activity; coexpression studies of the mutant protein with the wild-type protein produces significantly reduced currents suggesting a severe effect of the mutation [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
VAR_020831
COSM431247
CA341655
RCV000020219
rs28933383
226 T>M Episodic ataxia type 1 Variant assessed as Somatic; impact. breast EA1 [ClinVar, NCI-TCGA, Cosmic, UniProt] Yes ClinGen
cosmic curated
ClinVar
UniProt
Ensembl
NCI-TCGA
dbSNP
VAR_037101
RCV001731285
RCV001785451
CA341290
RCV000014436
rs28933383
226 T>R Episodic ataxia type 1 Variant assessed as Somatic; impact. Episodic ataxia/myokymia syndrome EA1; yields currents with a largely reduced amplitude [ClinVar, NCI-TCGA, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
NCI-TCGA
dbSNP
RCV000014425
rs104894348
CA256875
VAR_001511
239 R>S Episodic ataxia type 1 EA1 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs28933381
RCV000441803
VAR_037102
CA123136
RCV000014433
242 A>P Myokymia 1 MK1; 10% reduction of mean peak current amplitudes compared to wil-dtype; mutant and wild-type expression together is consistent with a loss-of-function effect of the mutation [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
VAR_037103
RCV000014434
rs28933382
CA123137
244 P>H Myokymia 1 MK1; does not affect channel activity [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
RCV000014427
CA256877
rs104894356
VAR_001512
249 F>I Episodic ataxia type 1 EA1 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs113994120
RCV002718822
250 F>missing Inborn genetic diseases [ClinVar] Yes ClinVar
dbSNP
RCV001227795
rs1947356316
253 I>F Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
RCV001238769
rs1947356316
253 I>V Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
RCV000014438
rs121918067
VAR_072397
CA123139
255 N>D Myokymia 1 with hypomagnesemia MK1; strongly reduces the activity of homomeric channels with dominant negative effects on wild-type channels [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV001049355
rs1947356506
265 Y>C Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs1555085756
RCV000559038
290 I>S Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs778463081
RCV001861968
RCV000712107
COSM282063
CA383455553
295 R>H Episodic ataxia type 1 large_intestine [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1315748120
RCV001240784
RCV001331075
296 L>F Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs1555085761
CA383455619
RCV000517456
RCV001775128
305 L>F Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1947357313
RCV001306801
306 S>C Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs1947357459
RCV001230891
311 G>C Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
rs1947357501
RCV001035616
312 L>I Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
RCV001782976
RCV000489690
CA383455679
rs1085308020
314 I>T Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV000700644
rs1565433425
CA383455729
322 S>R Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA256879
rs104894353
RCV000014429
VAR_020832
325 E>D Episodic ataxia type 1 EA1; results in non-functional homomeric channels; accelerates recovery from N-type inactivation due to interaction with KCNAB1; slows down N-type inactivation of heteromeric channels formed by KCNA1 and KCNA4 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
VAR_020833 329 L>I EA1 [UniProt] Yes UniProt
RCV001346621
rs1947357713
331 F>C Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
VAR_020834 342 S>I EA1; phenotype without myokymia [UniProt] Yes UniProt
RCV000522746
CA383456100
rs1555085786
RCV000709846
376 G>R Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001070525
rs1947358468
384 G>R Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
CA383456228
RCV000496443
rs1135401950
395 A>S Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001570793
RCV000190768
rs797044929
CA204814
401 A>V Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1591627924
RCV000798472
CA383456271
403 P>T Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs104894355
VAR_001513
CA256880
RCV000014431
RCV002509157
404 V>I Episodic ataxia type 1 Variant assessed as Somatic; impact. EA1; results in slower channel activation compared to wild-type; slows down N-type inactivation of heteromeric channels formed by KCNA1 and KCNA4 [ClinVar, NCI-TCGA, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
NCI-TCGA
dbSNP
RCV001266903
rs1947358808
RCV002290674
405 P>A Episodic ataxia type 1 Inborn genetic diseases [ClinVar] Yes ClinVar
dbSNP
rs1555085798
RCV000516981
CA383456286
VAR_078205
RCV001857907
405 P>L Episodic ataxia type 1 probable disease-associated variant found in a patient with neonatal onset epileptic encephalopathy [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
CA341286
rs104894352
VAR_001514
RCV000014424
408 V>A Episodic ataxia type 1 EA1; channels have voltage dependence similar to that of wild-type channels but with faster kinetics and increased C-type inactivation; accelerates recovery from N-type inactivation due to interaction with KCNAB1; slows down N-type inactivation of heteromeric channels formed by KCNA1 and KCNA4 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000014435
CA341288
rs104894358
417 R>* Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV001202824
rs1947359738
442 S>T Episodic ataxia type 1 [ClinVar] Yes ClinVar
dbSNP
RCV000175555
RCV000710151
RCV001088211
CA241309
rs150849316
443 R>G Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1481224137
RCV001861967
RCV002532927
CA383456574
RCV000712101
449 M>T Episodic ataxia type 1 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV002522229
CA10641544
rs886049512
RCV000355613
RCV000260786
455 M>K Episodic ataxia type 1 Hereditary episodic ataxia [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001321844
CA383456614
rs1173585397
455 M>V Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV001343292
CA6399499
rs767068909
461 M>T Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs1303950325
CA383456698
RCV000795802
466 A>D Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV001053938
rs150612442
CA6399508
472 N>S Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000802460
CA6399511
rs372539672
RCV000712103
483 Q>H Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA383456824
RCV000694631
rs1406153214
485 C>* Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA383456818
RCV001221068
rs1470787858
485 C>S Episodic ataxia type 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA6399323
rs762038042
2 T>R No ClinGen
ExAC
TOPMed
gnomAD
rs773128496
CA6399325
CA6399326
RCV000712099
4 M>I No ClinGen
ExAC
TOPMed
gnomAD
ClinVar
dbSNP
CA383453603
rs1358355196
4 M>V No ClinGen
TOPMed
rs962697658
CA231855278
6 G>A No ClinGen
gnomAD
rs962697658
CA383453617
6 G>E No ClinGen
gnomAD
COSM119670
rs754549386
CA231855270
6 G>R ovary [Cosmic] No ClinGen
cosmic curated
Ensembl
rs1194152428
CA383453635
9 V>L No ClinGen
TOPMed
gnomAD
rs1194152428
CA383453636
9 V>M No ClinGen
TOPMed
gnomAD
CA6399329
rs759152813
10 D>G No ClinGen
ExAC
gnomAD
CA383453650
rs1163240946
11 E>A No ClinGen
gnomAD
CA383453651
rs1163240946
11 E>V No ClinGen
gnomAD
rs1253210703
CA383453666
13 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 13 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752293178
CA6399331
14 A>S No ClinGen
ExAC
gnomAD
CA231855305
COSM459476
rs543311674
15 A>V pancreas Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
1000Genomes
NCI-TCGA
rs1360223867
CA383453681
16 P>L Variant assessed as Somatic; 4.646e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1360223867
CA383453679
16 P>Q No ClinGen
gnomAD
rs1565432905 16 P>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1338230248
CA383453693
18 H>Q No ClinGen
gnomAD
CA383453705
rs1243401360
20 Q>R No ClinGen
gnomAD
rs1237801961
CA383453718
22 G>D No ClinGen
gnomAD
rs755064500
CA6399338
25 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA383453742
TCGA novel
rs373645838
26 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
ESP
ExAC
gnomAD
rs1043625587
CA231855329
27 Q>R No ClinGen
Ensembl
CA231855337
rs904488099
28 A>V No ClinGen
Ensembl
CA383453788
rs1353118362
32 D>E No ClinGen
Ensembl
rs773288048
CA6399342
33 H>Q No ClinGen
ExAC
gnomAD
CA6399344
rs770814681
36 C>* No ClinGen
ExAC
gnomAD
CA383453814
rs1385867628
36 C>G No ClinGen
gnomAD
CA6399343
rs749152092
36 C>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA383453828
rs1380141950
38 R>C No ClinGen
gnomAD
CA383453830
rs1454599912
38 R>H No ClinGen
gnomAD
CA6399346
rs759476808
40 V>M No ClinGen
ExAC
gnomAD
TCGA novel 47 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA231855415
rs891898566
47 R>S No ClinGen
Ensembl
TCGA novel 49 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383453896
rs1384353122
49 E>Q No ClinGen
gnomAD
rs1308404461
CA383453917
52 L>I No ClinGen
gnomAD
CA6399351
rs370288610
53 K>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1240945980
CA383453923
53 K>Q No ClinGen
gnomAD
CA383453927
rs1253981772
53 K>R No ClinGen
gnomAD
rs1200027756
CA383453933
54 T>N No ClinGen
gnomAD
rs1412320343
CA383453944
56 A>E No ClinGen
TOPMed
CA383453951
rs1591627438
57 Q>R No ClinGen
Ensembl
TCGA novel 60 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6399356
rs552253837
66 P>S No ClinGen
1000Genomes
ExAC
gnomAD
CA383454015
rs1591627449
67 K>R No ClinGen
Ensembl
rs1220977526
CA383454033
70 M>V No ClinGen
TOPMed
CA383454044
rs1591627451
71 R>S No ClinGen
Ensembl
TCGA novel 76 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383454096
rs1312855741
78 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs998114173
CA231855452
79 E>* No ClinGen
TOPMed
gnomAD
TCGA novel 79 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383454123
rs1176706430
82 F>C No ClinGen
gnomAD
CA383454136
rs1007593832
84 R>G No ClinGen
TOPMed
gnomAD
rs1591627475
CA383454140
84 R>L No ClinGen
Ensembl
CA231855460
rs1007593832
84 R>S No ClinGen
TOPMed
gnomAD
CA383454144
rs1386750335
85 N>T No ClinGen
TOPMed
rs370669088
CA6399361
94 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA383454240
rs1223200683
99 G>R No ClinGen
gnomAD
rs1389942164
CA383454254
101 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 102 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA231855496
rs878882278
107 N>S No ClinGen
Ensembl
rs1481255492
CA383454300
109 P>S No ClinGen
gnomAD
rs1289420780
CA383454309
111 D>N No ClinGen
TOPMed
rs1265798670
CA383454322
112 M>I No ClinGen
gnomAD
rs776360582
CA6399367
112 M>V No ClinGen
ExAC
gnomAD
rs1224619978
TCGA novel
CA383454332
113 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
TOPMed
rs1273625044
CA383454339
115 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA6399369
rs764866873
116 E>Q No ClinGen
ExAC
gnomAD
CA231855519
rs201627497
117 I>V No ClinGen
1000Genomes
CA6399371
rs755315825
118 K>E No ClinGen
ExAC
TOPMed
gnomAD
rs768113136
CA6399372
118 K>R No ClinGen
ExAC
gnomAD
rs1226314295
CA383454378
120 Y>F No ClinGen
gnomAD
CA383454388
rs1304503648
121 E>D No ClinGen
TOPMed
rs1463513823
CA383454383
121 E>Q No ClinGen
TOPMed
gnomAD
rs958646499
CA231855547
127 M>L No ClinGen
TOPMed
rs958646499
CA231855552
127 M>V No ClinGen
TOPMed
rs1167052717
CA383454435
128 E>G No ClinGen
TOPMed
CA383454461
rs1198429123
132 E>K No ClinGen
TOPMed
CA383454485
rs1200292977
135 G>S No ClinGen
TOPMed
CA6399381
rs780062452
137 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA383454500
rs1264181777
137 I>V No ClinGen
TOPMed
gnomAD
RCV000761814
CA383454512
rs1565433107
139 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ClinVar
Ensembl
NCI-TCGA
dbSNP
rs746862982
CA6399382
142 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1591627571
CA383454544
143 P>R No ClinGen
Ensembl
CA383454542
rs1192462176
143 P>S No ClinGen
gnomAD
rs568025967
CA383454547
144 L>V No ClinGen
1000Genomes
ExAC
gnomAD
CA383454560
rs1425175027
146 E>G No ClinGen
gnomAD
rs772823472
CA6399387
146 E>K No ClinGen
ExAC
gnomAD
rs942544508
CA231855624
148 E>A No ClinGen
Ensembl
CA6399389
rs767728993
149 Y>H No ClinGen
ExAC
TOPMed
gnomAD
rs1288483498
CA383454610
153 V>L No ClinGen
gnomAD
TCGA novel 154 W>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6399391
rs761149222
156 L>V No ClinGen
ExAC
gnomAD
CA383454641
rs1359358525
158 E>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA231855641
rs1012333095
159 Y>S No ClinGen
Ensembl
rs754013861
CA6399393
161 E>* No ClinGen
ExAC
gnomAD
rs754013861
CA383454662
161 E>Q No ClinGen
ExAC
gnomAD
TCGA novel 163 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs779302041
CA6399395
164 G>V No ClinGen
ExAC
gnomAD
CA6399394
rs757392128
164 G>W No ClinGen
ExAC
rs1179635654
CA383454693
RCV000516865
166 A>P No ClinGen
ClinVar
dbSNP
gnomAD
CA383454694
rs1179635654
166 A>S No ClinGen
gnomAD
CA383454713
rs1165393723
169 I>V No ClinGen
gnomAD
RCV001093120
rs1947354204
170 A>T No ClinVar
dbSNP
rs779656199
CA6399398
172 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA383454749
rs1172417064
175 M>L No ClinGen
TOPMed
rs1433077411
CA383454751
175 M>T No ClinGen
gnomAD
TCGA novel 175 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768541186
CA6399400
178 L>I No ClinGen
ExAC
gnomAD
CA383454795
rs1464714743
182 V>F No ClinGen
TOPMed
CA383454800
rs1382106153
183 I>V No ClinGen
gnomAD
TCGA novel 187 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6399401
rs781075600
188 T>A No ClinGen
ExAC
gnomAD
CA383454839
rs1431772348
189 L>I No ClinGen
TOPMed
TCGA novel 191 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6399404
rs772878919
193 K>E No ClinGen
ExAC
TOPMed
gnomAD
COSM1299482
CA383454871
rs1299794605
194 D>N Variant assessed as Somatic; impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs267603503
CA231855691
197 D>V No ClinGen
Ensembl
rs1411072418
CA383454919
200 G>D No ClinGen
TOPMed
rs1179584499
CA383454923
201 T>A No ClinGen
TOPMed
rs1053557642
COSM292417
CA231855716
202 V>I large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
rs1185396833
CA383454936
203 H>P No ClinGen
gnomAD
rs1461354272
CA383454935
203 H>Y No ClinGen
TOPMed
gnomAD
rs557677390
CA6399406
206 D>G No ClinGen
1000Genomes
ExAC
gnomAD
rs1158938955
CA383454968
207 N>K No ClinGen
gnomAD
CA383454980
rs1565433235
209 T>M Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
TCGA novel 210 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6399407
rs775789299
211 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA6399408
rs761073190
213 N>K No ClinGen
ExAC
gnomAD
CA6399410
rs754350793
215 N>D No ClinGen
ExAC
gnomAD
rs762016621
CA6399411
215 N>S No ClinGen
ExAC
gnomAD
CA231855748
rs905998763
219 D>N No ClinGen
Ensembl
CA383455050
rs1217159263
220 P>L No ClinGen
gnomAD
rs906932631
CA231855756
221 F>S No ClinGen
TOPMed
CA383455073
rs766618582
223 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA383455113
rs1336919405
230 I>T No ClinGen
TOPMed
rs1034011056
CA231855795
230 I>V No ClinGen
TOPMed
rs1450956303
CA383455119
231 W>* No ClinGen
TOPMed
CA383455137
rs1234459228
233 S>C No ClinGen
gnomAD
CA6399420
rs755621934
234 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1428881435
CA6399421
237 V>M No ClinGen
TOPMed
gnomAD
CA383455166
rs1409849280
238 V>L No ClinGen
TOPMed
rs748830362
CA6399423
COSM940250
239 R>H Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1565433321
CA383455180
240 F>L No ClinGen
Ensembl
rs28933381
CA383455191
242 A>S No ClinGen
gnomAD
rs774035254
CA6399425
242 A>V No ClinGen
ExAC
gnomAD
rs140659450
CA6399426
243 C>G No ClinGen
ESP
ExAC
gnomAD
rs28933382
CA383455205
244 P>L No ClinGen
gnomAD
TCGA novel 246 K>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs71582856
CA231855845
247 T>A No ClinGen
Ensembl
CA383455226
rs1265751197
247 T>R No ClinGen
gnomAD
TCGA novel 252 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1345762772
CA383455271
253 I>S No ClinGen
gnomAD
rs1224911562
CA383455279
254 M>I No ClinGen
gnomAD
rs1196348315
CA383455320
260 V>L No ClinGen
gnomAD
rs377163970
CA6399431
263 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
RCV000722602
rs1565433356
CA383455376
268 T>K No ClinGen
ClinVar
Ensembl
dbSNP
TCGA novel 271 T>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 272 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1201839515
CA383455413
274 A>S No ClinGen
gnomAD
rs1201839515
CA383455411
274 A>T No ClinGen
gnomAD
rs373047882
CA6399436
274 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 279 N>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
RCV000992235
rs1591627786
CA383455452
279 N>K No ClinGen
ClinVar
Ensembl
dbSNP
rs777660284
CA6399438
283 E>D No ClinGen
ExAC
gnomAD
rs1284149306
CA383455507
287 S>C No ClinGen
TOPMed
rs923149331
CA231855948
289 A>T No ClinGen
TOPMed
rs376413513
CA231855949
290 I>V No ClinGen
ESP
gnomAD
rs1064796844
RCV000480540
CA16619546
291 L>H No ClinGen
ClinVar
Ensembl
dbSNP
CA383455550
rs1366571577
295 R>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs778463081
CA6399441
295 R>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 298 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA231855958
rs879016592
299 V>F No ClinGen
Ensembl
rs1591627824
CA383455577
299 V>G No ClinGen
Ensembl
rs555527499
CA6399443
303 F>L No ClinGen
1000Genomes
ExAC
gnomAD
rs77865785
CA6399444
306 S>P No ClinGen
ExAC
gnomAD
rs911314995
CA231855979
307 R>C No ClinGen
TOPMed
rs1162852829
CA383455652
310 K>R No ClinGen
TOPMed
TCGA novel 313 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 326 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752533303
CA6399453
332 F>S No ClinGen
ExAC
gnomAD
TCGA novel 335 I>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383455823
rs1447092753
336 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA231856067
rs946301494
338 I>V No ClinGen
TOPMed
gnomAD
TCGA novel 347 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 348 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383455915
COSM431249
rs1361446640
349 A>V Variant assessed as Somatic; 0.0 impact. large_intestine breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
TCGA novel 351 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 352 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA16043875
rs1057519226
RCV000416167
352 A>P No ClinGen
ClinVar
Ensembl
dbSNP
TCGA novel 352 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 353 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383455950
rs1259861866
354 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA383455974
rs1160426040
358 S>G No ClinGen
gnomAD
rs1205933159
CA383455991
360 P>L No ClinGen
gnomAD
CA383456011
rs1360069334
363 F>Y No ClinGen
TOPMed
rs1460015230
CA383456037
366 A>E No ClinGen
gnomAD
CA383456070
rs1183564005
371 T>I No ClinGen
gnomAD
CA6399467
rs774543663
379 Y>D No ClinGen
ExAC
TCGA novel 379 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs894238941
CA383456182
388 V>L No ClinGen
TOPMed
COSM346166
rs894238941
CA231856158
388 V>M lung large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
CA231856167
rs1015955746
395 A>G No ClinGen
TOPMed
VAR_016805 400 I>V RNA edited version [UniProt] No UniProt
CA231856195
rs867232553
403 P>L No ClinGen
Ensembl
CA341651
rs113994117
408 V>L No ClinGen
Ensembl
RCV000293427
CA10604040
rs113994117
408 V>M No ClinGen
ClinVar
Ensembl
dbSNP
rs1321610089
CA383456307
409 S>F No ClinGen
gnomAD
CA231856225
rs878940878
412 N>I No ClinGen
Ensembl
rs113994118
CA341653
414 F>C No ClinGen
Ensembl
CA383456363
rs104894358
417 R>G No ClinGen
gnomAD
TCGA novel 418 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs971990578
CA231856236
420 E>D No ClinGen
TOPMed
gnomAD
rs1204810478
CA383456409
423 E>D No ClinGen
TOPMed
rs979698553
COSM340961
CA231856240
424 Q>H lung [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA6399482
rs751215384
427 L>* No ClinGen
ExAC
gnomAD
CA6399481
rs779873859
427 L>M No ClinGen
ExAC
gnomAD
CA6399484
rs756549028
429 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA231856255
rs986001877
430 V>A No ClinGen
TOPMed
rs749598869
CA6399485
430 V>I No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 431 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1241721668
CA383456457
431 S>T No ClinGen
gnomAD
CA6399486
rs532197467
433 P>A No ClinGen
1000Genomes
ExAC
gnomAD
CA383456470
rs1392938918
433 P>R No ClinGen
gnomAD
CA6399487
rs745972916
COSM1255216
435 L>V Variant assessed as Somatic; 0.0 impact. oesophagus [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1565433579
CA383456491
436 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
TCGA novel 437 S>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs182735896
CA6399488
440 D>E No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs139383685
COSM170922
CA6399489
443 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
COSM216270
CA383456542
rs1352539698
444 R>H pancreas Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs768749436
CA6399490
445 S>G No ClinGen
ExAC
gnomAD
CA383456557
rs1225925083
446 S>F No ClinGen
gnomAD
TCGA novel 447 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383456568
rs1259409719
448 T>S No ClinGen
gnomAD
rs112561866
CA6399491
449 M>I No ClinGen
ExAC
gnomAD
TCGA novel 450 S>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761482576
CA383456582
450 S>I No ClinGen
ExAC
gnomAD
rs761482576
CA6399492
450 S>N No ClinGen
ExAC
gnomAD
CA383456591
rs765269318
451 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA6399494
rs773233842
452 S>P No ClinGen
ExAC
gnomAD
TCGA novel
rs1428218301
CA383456603
453 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
TOPMed
NCI-TCGA
rs762582185
CA6399495
453 E>G No ClinGen
ExAC
gnomAD
CA6399497
rs751268531
457 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA383456637
rs1430522715
COSM3812215
458 E>* Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA383456639
rs1373603066
458 E>G No ClinGen
gnomAD
rs1430522715
CA383456635
458 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA231856334
rs867618065
459 E>K No ClinGen
Ensembl
CA6399498
rs754731331
460 D>N No ClinGen
ExAC
gnomAD
rs1565433618
CA383456654
460 D>V No ClinGen
Ensembl
CA6399500
rs754282438
461 M>I No ClinGen
ExAC
gnomAD
TCGA novel 462 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383456704
rs368829607
467 H>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368829607
CA6399501
467 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs548263208
CA6399502
468 Y>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA6399504
rs758488049
469 R>G No ClinGen
ExAC
TCGA novel 469 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1225368736
CA383456716
469 R>K No ClinGen
TOPMed
rs867107765
CA231856357
470 Q>K No ClinGen
Ensembl
CA6399505
rs780167432
471 V>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs780167432
COSM940255
CA6399506
471 V>I Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA6399509
rs747996470
473 I>V No ClinGen
ExAC
gnomAD
CA231856379
rs139646303
474 R>G No ClinGen
ESP
TOPMed
rs937476417
CA231856386
476 A>S No ClinGen
Ensembl
CA383456766
rs1222837086
477 N>S No ClinGen
TOPMed
gnomAD
CA383456776
rs1484664630
478 C>* No ClinGen
gnomAD
CA383456773
rs1248121245
478 C>Y No ClinGen
TOPMed
gnomAD
rs769434101
CA6399510
480 T>A No ClinGen
ExAC
gnomAD
CA383456794
rs1430294104
481 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 485 C>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM1211395
CA383456826
rs766403463
486 V>I large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA6399512
rs766403463
486 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs1351841852
CA383456833
487 N>T No ClinGen
gnomAD
rs758933813
CA6399514
487 N>Y No ClinGen
ExAC
gnomAD
CA383456849
RCV000492814
rs1131691765
489 S>N No ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs1131691765
CA383456850
489 S>T No ClinGen
TOPMed
gnomAD
rs757648784
CA6399517
493 T>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD

2 associated diseases with Q09470

[MIM: 160120]: Episodic ataxia 1 (EA1)

An autosomal dominant disorder characterized by brief episodes of ataxia and dysarthria. Neurological examination during and between the attacks demonstrates spontaneous, repetitive discharges in the distal musculature (myokymia) that arise from peripheral nerve. Nystagmus is absent. {ECO:0000269|PubMed:10355668, ECO:0000269|PubMed:11013453, ECO:0000269|PubMed:11026449, ECO:0000269|PubMed:12077175, ECO:0000269|PubMed:15532032, ECO:0000269|PubMed:17156368, ECO:0000269|PubMed:7842011, ECO:0000269|PubMed:8541859, ECO:0000269|PubMed:8845167, ECO:0000269|PubMed:8871592, ECO:0000269|PubMed:9600245}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 160120]: Myokymia isolated 1 (MK1)

A condition characterized by spontaneous involuntary contraction of muscle fiber groups that can be observed as vermiform movement of the overlying skin. Electromyography typically shows continuous motor unit activity with spontaneous oligo- and multiplet-discharges of high intraburst frequency (myokymic discharges). Isolated spontaneous muscle twitches occur in many persons and have no grave significance. {ECO:0000269|PubMed:11026449, ECO:0000269|PubMed:17136396, ECO:0000269|PubMed:19307729, ECO:0000269|PubMed:19903818}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal dominant disorder characterized by brief episodes of ataxia and dysarthria. Neurological examination during and between the attacks demonstrates spontaneous, repetitive discharges in the distal musculature (myokymia) that arise from peripheral nerve. Nystagmus is absent. {ECO:0000269|PubMed:10355668, ECO:0000269|PubMed:11013453, ECO:0000269|PubMed:11026449, ECO:0000269|PubMed:12077175, ECO:0000269|PubMed:15532032, ECO:0000269|PubMed:17156368, ECO:0000269|PubMed:7842011, ECO:0000269|PubMed:8541859, ECO:0000269|PubMed:8845167, ECO:0000269|PubMed:8871592, ECO:0000269|PubMed:9600245}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • A condition characterized by spontaneous involuntary contraction of muscle fiber groups that can be observed as vermiform movement of the overlying skin. Electromyography typically shows continuous motor unit activity with spontaneous oligo- and multiplet-discharges of high intraburst frequency (myokymic discharges). Isolated spontaneous muscle twitches occur in many persons and have no grave significance. {ECO:0000269|PubMed:11026449, ECO:0000269|PubMed:17136396, ECO:0000269|PubMed:19307729, ECO:0000269|PubMed:19903818}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for Q09470

Type Name Position InterPro Accession
domain BTB/POZ domain 37 - 137 IPR000210
domain Potassium channel tetramerisation-type BTB domain 39 - 130 IPR003131
domain Ion transport domain 167 - 418 IPR005821

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
  • Membrane
  • Cell projection, axon
  • Cytoplasmic vesicle
  • Perikaryon
  • Endoplasmic reticulum
  • Cell projection, dendrite
  • Cell junction
  • Synapse
  • Presynaptic cell membrane
  • Presynapse
  • Homotetrameric KCNA1 is primarily located in the endoplasmic reticulum
  • Interaction with KCNA2 and KCNAB2 or with KCNA4 and KCNAB2 promotes expression at the cell membrane (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

24 GO annotations of cellular component

Name Definition
anchoring junction A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix.
apical plasma membrane The region of the plasma membrane located at the apical end of the cell.
axon initial segment Portion of the axon proximal to the neuronal cell body, at the level of the axon hillock. The action potentials that propagate along the axon are generated at the level of this initial segment.
axon terminus Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal button is a specialized region of it.
calyx of Held The terminal specialization of a calyciferous axon which forms large synapses in the mammalian auditory central nervous system.
cell junction A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella.
cell surface The external part of the cell wall and/or plasma membrane.
cytoplasmic vesicle A vesicle found in the cytoplasm of a cell.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
dendrite A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
glutamatergic synapse A synapse that uses glutamate as a neurotransmitter.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of postsynaptic membrane The component of the postsynaptic membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of presynaptic membrane The component of the presynaptic membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
juxtaparanode region of axon A region of an axon near a node of Ranvier that is between the paranode and internode regions.
neuronal cell body The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
paranode region of axon An axon part that is located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of myelin sheath.
perikaryon The portion of the cell soma (neuronal cell body) that excludes the nucleus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
presynaptic membrane A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
voltage-gated potassium channel complex A protein complex that forms a transmembrane channel through which potassium ions may cross a cell membrane in response to changes in membrane potential.

7 GO annotations of molecular function

Name Definition
delayed rectifier potassium channel activity Enables the transmembrane transfer of a potassium ion by a delayed rectifying voltage-gated channel. A delayed rectifying current-voltage relation is one where channel activation kinetics are time-dependent, and inactivation is slow.
disordered domain specific binding Binding to a disordered domain of a protein.
potassium channel activity Enables the facilitated diffusion of a potassium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
potassium ion transmembrane transporter activity Enables the transfer of potassium ions (K+) from one side of a membrane to the other.
voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential Any voltage-gated ion channel activity that is involved in regulation of postsynaptic membrane potential.
voltage-gated ion channel activity involved in regulation of presynaptic membrane potential Voltage-gated ion channel activity, occurring in the presynaptic membrane, involved in regulation of presynaptic membrane potential. This is a key step in synaptic transmission, following the arrival of an action potential at the synapse.
voltage-gated potassium channel activity Enables the transmembrane transfer of a potassium ion by a voltage-gated channel. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.

19 GO annotations of biological process

Name Definition
cell communication by electrical coupling The process that mediates signaling interactions between one cell and another cell by transfer of current between their adjacent cytoplasms via intercellular protein channels.
cellular response to magnesium ion Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus.
chemical synaptic transmission The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
detection of mechanical stimulus involved in sensory perception of pain The series of events involved in the perception of pain in which a mechanical stimulus is received and converted into a molecular signal.
detection of mechanical stimulus involved in sensory perception of touch The series of events involved in the perception of touch in which a mechanical stimulus is received and converted into a molecular signal.
hippocampus development The progression of the hippocampus over time from its initial formation until its mature state.
magnesium ion homeostasis Any process involved in the maintenance of an internal steady state of magnesium ions within an organism or cell.
neuroblast proliferation The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron.
neuromuscular process Any process pertaining to the functions of the nervous and muscular systems of an organism.
neuronal action potential An action potential that occurs in a neuron.
neuronal signal transduction The process in which an activated neuronal cell receptor conveys information down a signaling pathway, resulting in a change in the function or state of a cell. This process may be intracellular or intercellular.
positive regulation of voltage-gated potassium channel activity Any process that activates or increases the frequency, rate or extent of voltage-gated potassium channel activity.
potassium ion transmembrane transport A process in which a potassium ion is transported from one side of a membrane to the other.
potassium ion transport The directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
protein homooligomerization The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
protein localization Any process in which a protein is transported to, or maintained in, a specific location.
regulation of membrane potential Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
regulation of muscle contraction Any process that modulates the frequency, rate or extent of muscle contraction.
startle response An action or movement due to the application of a sudden unexpected stimulus.

22 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q05037 KCNA4 Potassium voltage-gated channel subfamily A member 4 Bos taurus (Bovine) PR
Q7T199 KCNA10 Potassium voltage-gated channel subfamily A member 10 Gallus gallus (Chicken) PR
P22001 KCNA3 Potassium voltage-gated channel subfamily A member 3 Homo sapiens (Human) PR
P22459 KCNA4 Potassium voltage-gated channel subfamily A member 4 Homo sapiens (Human) PR
Q16322 KCNA10 Potassium voltage-gated channel subfamily A member 10 Homo sapiens (Human) PR
Q96RP8 KCNA7 Potassium voltage-gated channel subfamily A member 7 Homo sapiens (Human) PR
Q9ULS6 KCNS2 Potassium voltage-gated channel subfamily S member 2 Homo sapiens (Human) PR
Q9H3M0 KCNF1 Potassium voltage-gated channel subfamily F member 1 Homo sapiens (Human) PR
Q14721 KCNB1 Potassium voltage-gated channel subfamily B member 1 Homo sapiens (Human) PR
Q8TDN2 KCNV2 Potassium voltage-gated channel subfamily V member 2 Homo sapiens (Human) PR
Q92953 KCNB2 Potassium voltage-gated channel subfamily B member 2 Homo sapiens (Human) PR
P16389 KCNA2 Potassium voltage-gated channel subfamily A member 2 Homo sapiens (Human) PR
Q9UK17 KCND3 Potassium voltage-gated channel subfamily D member 3 Homo sapiens (Human) PR
Q03721 KCNC4 Potassium voltage-gated channel subfamily C member 4 Homo sapiens (Human) PR
Q61423 Kcna4 Potassium voltage-gated channel subfamily A member 4 Mus musculus (Mouse) PR
P16390 Kcna3 Potassium voltage-gated channel subfamily A member 3 Mus musculus (Mouse) PR
Q17ST2 Kcna7 Potassium voltage-gated channel subfamily A member 7 Mus musculus (Mouse) PR
P16388 Kcna1 Potassium voltage-gated channel subfamily A member 1 Mus musculus (Mouse) PR
P15385 Kcna4 Potassium voltage-gated channel subfamily A member 4 Rattus norvegicus (Rat) PR
P15384 Kcna3 Potassium voltage-gated channel subfamily A member 3 Rattus norvegicus (Rat) PR
P63142 Kcna2 Potassium voltage-gated channel subfamily A member 2 Rattus norvegicus (Rat) PR
P10499 Kcna1 Potassium voltage-gated channel subfamily A member 1 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MTVMSGENVD EASAAPGHPQ DGSYPRQADH DDHECCERVV INISGLRFET QLKTLAQFPN
70 80 90 100 110 120
TLLGNPKKRM RYFDPLRNEY FFDRNRPSFD AILYYYQSGG RLRRPVNVPL DMFSEEIKFY
130 140 150 160 170 180
ELGEEAMEKF REDEGFIKEE ERPLPEKEYQ RQVWLLFEYP ESSGPARVIA IVSVMVILIS
190 200 210 220 230 240
IVIFCLETLP ELKDDKDFTG TVHRIDNTTV IYNSNIFTDP FFIVETLCII WFSFELVVRF
250 260 270 280 290 300
FACPSKTDFF KNIMNFIDIV AIIPYFITLG TEIAEQEGNQ KGEQATSLAI LRVIRLVRVF
310 320 330 340 350 360
RIFKLSRHSK GLQILGQTLK ASMRELGLLI FFLFIGVILF SSAVYFAEAE EAESHFSSIP
370 380 390 400 410 420
DAFWWAVVSM TTVGYGDMYP VTIGGKIVGS LCAIAGVLTI ALPVPVIVSN FNYFYHRETE
430 440 450 460 470 480
GEEQAQLLHV SSPNLASDSD LSRRSSSTMS KSEYMEIEED MNNSIAHYRQ VNIRTANCTT
490
ANQNCVNKSK LLTDV